{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:13:44Z","timestamp":1786979624679,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00115-021-01204-y","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T05:45:09Z","timestamp":1634276709000},"page":"135-141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Neugeborenenscreeningprogramm f\u00fcr die spinale Muskelatrophie","Newborn screening program for spinal muscular atrophy"],"prefix":"10.1007","volume":"93","author":[{"given":"Heike","family":"K\u00f6lbel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Vill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Blaschek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Nennstiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Schara-Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg F.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Gl\u00e4ser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wulf","family":"R\u00f6schinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnther","family":"Bernert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"M\u00fcller-Felber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"key":"1204_CR1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1146\/annurev-genom-102319-103602","volume":"21","author":"B Wirth","year":"2020","unstructured":"Wirth\u00a0B, Karakaya\u00a0M, Kye\u00a0MJ, Mendoza-Ferreira\u00a0N (2020) Twenty-five years of spinal muscular atrophy research: from phenotype to genotype to therapy, and what comes next. Annu Rev Genomics Hum Genet 21:231\u2013261","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"4","key":"1204_CR2","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nrneurol.2018.4","volume":"14","author":"EJN Groen","year":"2018","unstructured":"Groen\u00a0EJN, Talbot\u00a0K, Gillingwater\u00a0TH (2018) Advances in therapy for spinal muscular atrophy: promises and challenges. Nat Rev Neurol 14(4):214\u2013224","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"1204_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.bbagrm.2016.12.008","volume":"1860","author":"RN Singh","year":"2017","unstructured":"Singh\u00a0RN, Howell\u00a0MD, Ottesen\u00a0EW, Singh\u00a0NN (2017) Diverse role of survival motor neuron protein. Biochim Biophys Acta 1860(3):299\u2013315","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"1204_CR4","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.nmd.2018.01.003","volume":"28","author":"M Calucho","year":"2018","unstructured":"Calucho\u00a0M, Bernal\u00a0S, Alias\u00a0L, March\u00a0F, Vencesla\u00a0A, Rodriguez-Alvarez\u00a0FJ, Aller\u00a0E, Fernandez\u00a0RM, Borrego\u00a0S, Millan\u00a0JM et al (2018) Correlation between SMA type and SMN2 copy number revisited: an analysis of 625 unrelated Spanish patients and a\u00a0compilation of 2834 reported cases. Neuromuscul Disord 28(3):208\u2013215","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"1204_CR5","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1086\/338627","volume":"70","author":"M Feldkotter","year":"2002","unstructured":"Feldkotter\u00a0M, Schwarzer\u00a0V, Wirth\u00a0R, Wienker\u00a0TF, Wirth\u00a0B (2002) Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet 70(2):358\u2013368","journal-title":"Am J Hum Genet"},{"issue":"3","key":"1204_CR6","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.gde.2013.03.003","volume":"23","author":"B Wirth","year":"2013","unstructured":"Wirth\u00a0B, Garbes\u00a0L, Riessland\u00a0M (2013) How genetic modifiers influence the phenotype of spinal muscular atrophy and suggest future therapeutic approaches. Curr Opin Genet Dev 23(3):330\u2013338","journal-title":"Curr Opin Genet Dev"},{"issue":"1","key":"1204_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.nmd.2019.11.002","volume":"30","author":"T Dangouloff","year":"2020","unstructured":"Dangouloff\u00a0T, Burghes\u00a0A, Tizzano\u00a0EF, Servais\u00a0L (2020) 244th ENMC international workshop: newborn screening in spinal muscular atrophy May 10\u201312, 2019, Hoofdorp, the Netherlands. Neuromuscul Disord 30(1):93\u2013103","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"1204_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3233\/JND-190468","volume":"7","author":"J Glascock","year":"2020","unstructured":"Glascock\u00a0J, Sampson\u00a0J, Connolly\u00a0AM, Darras\u00a0BT, Day\u00a0JW, Finkel\u00a0R, Howell\u00a0RR, Klinger\u00a0KW, Kuntz\u00a0N, Prior\u00a0T et\u00a0al (2020) Revised recommendations for the treatment of infants diagnosed with spinal muscular atrophy via newborn screening who have 4 copies of SMN2. J\u00a0Neuromuscul Dis 7(2):97\u2013100","journal-title":"J Neuromuscul Dis"},{"issue":"2","key":"1204_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3233\/JND-180304","volume":"5","author":"J Glascock","year":"2018","unstructured":"Glascock\u00a0J, Sampson\u00a0J, Haidet-Phillips\u00a0A, Connolly\u00a0A, Darras\u00a0B, Day\u00a0J, Finkel\u00a0R, Howell\u00a0RR, Klinger\u00a0K, Kuntz\u00a0N et al (2018) Treatment algorithm for infants diagnosed with spinal muscular atrophy through newborn screening. J\u00a0Neuromuscul Dis 5(2):145\u2013158. https:\/\/doi.org\/10.3233\/JND-180304","journal-title":"J Neuromuscul Dis"},{"issue":"4","key":"1204_CR10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3233\/JND-190428","volume":"6","author":"K Vill","year":"2019","unstructured":"Vill\u00a0K, Kolbel\u00a0H, Schwartz\u00a0O, Blaschek\u00a0A, Olgemoller\u00a0B, Harms\u00a0E, Burggraf\u00a0S, Roschinger\u00a0W, Durner\u00a0J, Glaser\u00a0D et\u00a0al (2019) One year of newborn screening for SMA\u2014results of a\u00a0German pilot project. J\u00a0Neuromuscul Dis 6(4):503\u2013515","journal-title":"J Neuromuscul Dis"},{"issue":"5","key":"1204_CR11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.nmd.2019.02.003","volume":"29","author":"F Boemer","year":"2019","unstructured":"Boemer\u00a0F, Caberg\u00a0J\u2011H, Dideberg\u00a0V, Dardenne\u00a0D, Bours\u00a0V, Hiligsmann\u00a0M, Dangouloff\u00a0T, Servais\u00a0L (2019) Newborn screening for SMA in Southern Belgium. Neuromuscul Disord 29(5):343\u2013349","journal-title":"Neuromuscul Disord"},{"key":"1204_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jpeds.2017.06.042","volume":"190","author":"YH Chien","year":"2017","unstructured":"Chien\u00a0YH, Chiang\u00a0SC, Weng\u00a0WC, Lee\u00a0NC, Lin\u00a0CJ, Hsieh\u00a0WS, Lee\u00a0WT, Jong\u00a0YJ, Ko\u00a0TM, Hwu\u00a0WL (2017) Presymptomatic diagnosis of spinal muscular atrophy through newborn screening. J\u00a0Pediatr 190:124\u2013129.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2017.06.042","journal-title":"J Pediatr"},{"issue":"8","key":"1204_CR13","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1177\/0883073807305788","volume":"22","author":"CH Wang","year":"2007","unstructured":"Wang\u00a0CH, Finkel\u00a0RS, Bertini\u00a0ES, Schroth\u00a0M, Simonds\u00a0A, Wong\u00a0B, Aloysius\u00a0A, Morrison\u00a0L, Main\u00a0M, Crawford\u00a0TO et\u00a0al (2007) Consensus statement for standard of care in spinal muscular atrophy. J\u00a0Child Neurol 22(8):1027\u20131049","journal-title":"J Child Neurol"},{"issue":"4","key":"1204_CR14","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s00439-006-0156-7","volume":"119","author":"B Wirth","year":"2006","unstructured":"Wirth\u00a0B, Brichta\u00a0L, Schrank\u00a0B, Lochm\u00fcller\u00a0H, Blick\u00a0S, Baasner\u00a0A, Heller\u00a0R (2006) Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number. Hum Genet 119(4):422\u2013428","journal-title":"Hum Genet"},{"issue":"8983","key":"1204_CR15","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/S0140-6736(95)91835-3","volume":"346","author":"K Zerres","year":"1995","unstructured":"Zerres\u00a0K, Rudnik-Sch\u00f6neborn\u00a0S, Forkert\u00a0R, Wirth\u00a0B (1995) Genetic basis of adult-onset spinal muscular atrophy. Lancet 346(8983):1162","journal-title":"Lancet"},{"issue":"2","key":"1204_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","volume":"28","author":"E Mercuri","year":"2018","unstructured":"Mercuri\u00a0E, Finkel\u00a0RS, Muntoni\u00a0F, Wirth\u00a0B, Montes\u00a0J, Main\u00a0M, Mazzone\u00a0ES, Vitale\u00a0M, Snyder\u00a0B, Quijano-Roy\u00a0S et al (2018) Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord 28(2):103\u2013115. https:\/\/doi.org\/10.1016\/j.nmd.2017.11.005","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"1204_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.nmd.2017.11.004","volume":"28","author":"RS Finkel","year":"2018","unstructured":"Finkel\u00a0RS, Mercuri\u00a0E, Meyer\u00a0OH, Simonds\u00a0AK, Schroth\u00a0MK, Graham\u00a0RJ, Kirschner\u00a0J, Iannaccone\u00a0ST, Crawford\u00a0TO, Woods\u00a0S et\u00a0al (2018) Diagnosis and management of spinal muscular atrophy: part 2: pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscul Disord 28(3):197\u2013207. https:\/\/doi.org\/10.1016\/j.nmd.2017.11.004","journal-title":"Neuromuscul Disord"},{"issue":"10","key":"1204_CR18","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.nmd.2017.05.011","volume":"27","author":"EF Tizzano","year":"2017","unstructured":"Tizzano\u00a0EF, Finkel\u00a0RS (2017) Spinal muscular atrophy: a changing phenotype beyond the clinical trials. Neuromuscul Disord 27(10):883\u2013889","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"1204_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3233\/JND-200475","volume":"7","author":"W M\u00fcller-Felber","year":"2020","unstructured":"M\u00fcller-Felber\u00a0W, Vill\u00a0K, Schwartz\u00a0O, Gl\u00e4ser\u00a0D, Nennstiel\u00a0U, Wirth\u00a0B, Burggraf\u00a0S, R\u00f6schinger\u00a0W, Becker\u00a0M, Durner\u00a0J et al (2020) Infants diagnosed with spinal muscular atrophy and 4 SMN2 copies through newborn screening\u2014opportunity or burden? J\u00a0Neuromuscul Dis 7(2):109\u2013117","journal-title":"J Neuromuscul Dis"},{"issue":"4","key":"1204_CR20","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.tins.2020.11.009","volume":"44","author":"B Wirth","year":"2021","unstructured":"Wirth\u00a0B (2021) Spinal muscular atrophy: in the challenge lies a\u00a0solution. Trends Neurosci 44(4):306\u2013322","journal-title":"Trends Neurosci"},{"issue":"3","key":"1204_CR21","doi-asserted-by":"publisher","first-page":"e0230677","DOI":"10.1371\/journal.pone.0230677","volume":"15","author":"MC Pera","year":"2020","unstructured":"Pera\u00a0MC, Coratti\u00a0G, Berti\u00a0B, D\u2019Amico\u00a0A, Sframeli\u00a0M, Albamonte\u00a0E, de Sanctis\u00a0R, Messina\u00a0S, Catteruccia\u00a0M, Brigati\u00a0G et\u00a0al (2020) Diagnostic journey in spinal muscular atrophy: is it still an odyssey? PLoS ONE 15(3):e230677","journal-title":"PLoS ONE"},{"issue":"18","key":"1204_CR22","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel\u00a0RS, Mercuri\u00a0E, Darras\u00a0BT, Connolly\u00a0AM, Kuntz\u00a0NL, Kirschner\u00a0J, Chiriboga\u00a0CA, Saito\u00a0K, Servais\u00a0L, Tizzano\u00a0E et al (2017) Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N\u00a0Engl J Med 377(18):1723\u20131732","journal-title":"N Engl J Med"},{"issue":"11","key":"1204_CR23","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.nmd.2019.09.007","volume":"29","author":"DC De Vivo","year":"2019","unstructured":"De Vivo\u00a0DC, Bertini\u00a0E, Swoboda\u00a0KJ, Hwu\u00a0WL, Crawford\u00a0TO, Finkel\u00a0RS, Kirschner\u00a0J, Kuntz\u00a0NL, Parsons\u00a0JA, Ryan\u00a0MM et\u00a0al (2019) Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: interim efficacy and safety results from the phase 2 NURTURE study. Neuromuscul Disord 29(11):842\u2013856. https:\/\/doi.org\/10.1016\/j.nmd.2019.09.007","journal-title":"Neuromuscul Disord"},{"key":"1204_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.pediatrneurol.2019.05.005","volume":"98","author":"LP Lowes","year":"2019","unstructured":"Lowes\u00a0LP, Alfano\u00a0LN, Arnold\u00a0WD, Shell\u00a0R, Prior\u00a0TW, McColly\u00a0M, Lehman\u00a0KJ, Church\u00a0K, Sproule\u00a0DM, Nagendran\u00a0S et al (2019) Impact of age and motor function in a\u00a0phase 1\/2A study of infants with SMA type 1 receiving single-dose gene replacement therapy. Pediatr Neurol 98:39\u201345","journal-title":"Pediatr Neurol"},{"key":"1204_CR25","volume-title":"Newborn screening for 5q-linked spinal muscular atrophy","author":"Institute for Quality and Efficiency in Health Care","year":"2020","unstructured":"Institute for Quality and Efficiency in Health Care (2020) Newborn screening for 5q-linked spinal muscular atrophy. Institute for Quality and Efficiency in Health Care (IQWiG)\u00a9, Cologne (IQWiG Reports\u2014Commission No S18-02)"},{"issue":"1","key":"1204_CR26","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13023-021-01783-8","volume":"16","author":"K Vill","year":"2021","unstructured":"Vill\u00a0K, Schwartz\u00a0O, Blaschek\u00a0A, Gl\u00e4ser\u00a0D, Nennstiel\u00a0U, Wirth\u00a0B, Burggraf\u00a0S, R\u00f6schinger\u00a0W, Becker\u00a0M, Czibere\u00a0L et\u00a0al (2021) Newborn screening for spinal muscular atrophy in Germany: clinical results after 2\u00a0years. Orphanet J Rare Dis 16(1):153","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"1204_CR27","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13023-019-1125-2","volume":"14","author":"K Konig","year":"2019","unstructured":"Konig\u00a0K, Pechmann\u00a0A, Thiele\u00a0S, Walter\u00a0MC, Schorling\u00a0D, Tassoni\u00a0A, Lochmuller\u00a0H, Muller-Reible\u00a0C, Kirschner\u00a0J (2019) De-duplicating patient records from three independent data sources reveals the incidence of rare neuromuscular disorders in Germany. Orphanet J Rare Dis 14(1):152","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"1204_CR28","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13023-017-0671-8","volume":"12","author":"IEC Verhaart","year":"2017","unstructured":"Verhaart\u00a0IEC, Robertson\u00a0A, Wilson\u00a0IJ, Aartsma-Rus\u00a0A, Cameron\u00a0S, Jones\u00a0CC, Cook\u00a0SF, Lochmuller\u00a0H (2017) Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy\u2014a\u00a0literature review. Orphanet J Rare Dis 12(1):124","journal-title":"Orphanet J Rare Dis"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-021-01204-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-021-01204-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-021-01204-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T05:04:14Z","timestamp":1644296654000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-021-01204-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1204"],"URL":"https:\/\/doi.org\/10.1007\/s00115-021-01204-y","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]},"assertion":[{"value":"13 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"H.\u00a0K\u00f6lbel gibt an: Vortr\u00e4ge in Industriesymposien (Pfizer, Roche, Novartis und Sanofi) und Advisory Board (Avexis\/Novarti). K.\u00a0Vill gibt an: Vortragshonorare und Reisekostenzusch\u00fcsse (Biogen und Santhera). O.\u00a0Schwartz gibt an: Vortr\u00e4ge in Industriesymposien (Roche, Biogen). A.\u00a0Blaschek gibt an: Vortr\u00e4ge in Industriesymposien (Roche, Novartis und Sanofi). U.\u00a0Schara-Schmidt gibt an: Vortr\u00e4ge in Industriesymposien (Roche, Biogen), Advisory Board (Roche, Biogen und Avexis). G.\u00a0Bernert gibt an: Vortr\u00e4ge in Industriesymposien (Roche, Biogen), Advisory Board (Roche, Biogen und Avexis). A.\u00a0Klein gibt an: Vortr\u00e4ge in Industriesymposien (Roche, Biogen), Advisory Board (Roche, Biogen und Novartis). W.\u00a0M\u00fcller-Felber gibt an: Vortr\u00e4ge in Industriesymposien (Avexis, Roche, Biogen), Advisory Board (Roche, Biogen und Avexis). U.\u00a0Nennstiel, G.F.\u00a0Hoffmann, D.\u00a0Gl\u00e4ser und W.\u00a0R\u00f6schinger geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Alle beschriebenen Untersuchungen am Menschen oder an menschlichem Gewebe wurden mit Zustimmung der zust\u00e4ndigen Ethikkommission, im Einklang mit nationalem Recht sowie gem\u00e4\u00df der Deklaration von Helsinki von 1975 (in der aktuellen, \u00fcberarbeiteten Fassung) durchgef\u00fchrt. Von allen beteiligten Patienten liegt eine Einverst\u00e4ndniserkl\u00e4rung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}